SCM
Schnieders Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $275K | Sell |
678
-37
| -5% | -$15K | 0.05% | 190 |
|
|
2025
Q1 | $356K | Hold |
715
| – | – | 0.08% | 148 |
|
|
2024
Q4 | $372K | Buy |
715
+5
| +0.7% | +$2.6K | 0.07% | 147 |
|
|
2024
Q3 | $439K | Buy |
710
+70
| +11% | +$43.3K | 0.08% | 141 |
|
|
2024
Q2 | $354K | Hold |
640
| – | – | 0.07% | 147 |
|
|
2024
Q1 | $372K | Sell |
640
-139
| -18% | -$80.8K | 0.08% | 144 |
|
|
2023
Q4 | $413K | Hold |
779
| – | – | 0.09% | 130 |
|
|
2023
Q3 | $394K | Hold |
779
| – | – | 0.09% | 129 |
|
|
2023
Q2 | $406K | Hold |
779
| – | – | 0.08% | 136 |
|
|
2023
Q1 | $449K | Hold |
779
| – | – | 0.1% | 131 |
|
|
2022
Q4 | $429K | Hold |
779
| – | – | 0.1% | 129 |
|
|
2022
Q3 | $395K | Hold |
779
| – | – | 0.1% | 129 |
|
|
2022
Q2 | $423K | Buy |
779
+285
| +58% | +$155K | 0.13% | 120 |
|
|
2022
Q1 | $292K | Buy |
494
+107
| +28% | +$63.2K | 0.07% | 164 |
|
|
2021
Q4 | $258K | Hold |
387
| – | – | 0.06% | 171 |
|
|
2021
Q3 | $221K | Buy |
+387
| New | +$221K | 0.06% | 179 |
|